Kopp Investment Advisors LLC lessened its stake in shares of Teligent Inc (NASDAQ:TLGT) by 21.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 766,295 shares of the company’s stock after selling 211,943 shares during the quarter. Teligent makes up approximately 2.3% of Kopp Investment Advisors LLC’s investment portfolio, making the stock its 20th biggest holding. Kopp Investment Advisors LLC’s holdings in Teligent were worth $2,651,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in TLGT. Spark Investment Management LLC purchased a new stake in Teligent during the 1st quarter valued at $162,000. JPMorgan Chase & Co. raised its holdings in Teligent by 225.7% during the 1st quarter. JPMorgan Chase & Co. now owns 33,731 shares of the company’s stock valued at $274,000 after buying an additional 23,376 shares during the period. Raymond James Financial Services Advisors Inc. raised its holdings in Teligent by 83.9% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 94,443 shares of the company’s stock valued at $327,000 after buying an additional 43,091 shares during the period. Deutsche Bank AG raised its holdings in Teligent by 82.5% during the 4th quarter. Deutsche Bank AG now owns 90,938 shares of the company’s stock valued at $329,000 after buying an additional 41,119 shares during the period. Finally, Citadel Advisors LLC raised its holdings in Teligent by 86.2% during the 1st quarter. Citadel Advisors LLC now owns 114,784 shares of the company’s stock valued at $385,000 after buying an additional 53,141 shares during the period. Institutional investors own 68.76% of the company’s stock.

NASDAQ:TLGT traded down $0.04 during midday trading on Friday, hitting $3.66. 1,368 shares of the company traded hands, compared to its average volume of 242,993. The company has a debt-to-equity ratio of 3.31, a quick ratio of 1.79 and a current ratio of 2.77. Teligent Inc has a 12-month low of $2.43 and a 12-month high of $7.34. The firm has a market capitalization of $198.63 million, a PE ratio of -19.52 and a beta of 1.09.

In other Teligent news, CEO Jason Grenfell-Gardner sold 52,800 shares of the stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $4.00, for a total value of $211,200.00. Following the sale, the chief executive officer now owns 94,949 shares in the company, valued at $379,796. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 22.80% of the company’s stock.

Several analysts recently weighed in on TLGT shares. ValuEngine upgraded Teligent from a “hold” rating to a “buy” rating in a report on Friday, August 10th. Canaccord Genuity set a $4.00 price target on Teligent and gave the company a “hold” rating in a report on Monday, August 13th. Finally, Zacks Investment Research upgraded Teligent from a “sell” rating to a “hold” rating in a report on Friday, June 22nd.

About Teligent

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Recommended Story: Stock Symbols Definition, Examples, Lookup

Want to see what other hedge funds are holding TLGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teligent Inc (NASDAQ:TLGT).

Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.